A prescription label connects the medication you received with the directions intended for you. For a compounded NAD+ product, the exact preparation can matter. A photograph on a website or another person’s instructions cannot replace the label and the dispensing pharmacist’s guidance.
This guide helps you prepare questions; it deliberately does not provide a universal dose, syringe conversion, storage temperature, or usable life. Those details need to come from the professionals responsible for your actual prescription.
The actual dispensing label and pharmacist determine the instructions. Resolve any mismatch before use; do not calculate a personal dose from a review site.
Match the shipment to the prescription
Check that the patient details, pharmacy, medication name, and administration route match what you discussed. Confirm that the supplied device and any supporting instructions belong to this preparation. Keep the pharmacy’s contact information where you can find it easily.
If something is missing or inconsistent, contact the pharmacist before use. Do not assume a difference is only a packaging change. A refill may have a different concentration or device even when the brand of the online service is unchanged.
Concentration and syringe markings are different information
A concentration describes how much ingredient is present in a given volume. A syringe marking describes a measurement on a particular device. The prescription needs to make the relationship between the supplied product and the intended amount clear to you.
Ask the pharmacist to explain any unit you do not understand using the actual product and device. Do not use a conversion posted for another vial, borrow instructions from an IV protocol, or change an amount to stretch a supply. The route comparison explains why route-specific instructions matter.
Use the product-specific storage instructions
Ask what conditions apply before opening, after first use, and during travel. Confirm the beyond-use date and any separate limit after opening. A larger vial is not useful value if its allowed use period ends before the prescribed course uses it.
If you travel, discuss transport with the pharmacist before departure. Do not choose a storage method based on a generic NAD+ article, and do not assume a product can tolerate a temperature change because it looks normal afterward.
Handle delivery concerns before using the product
If a parcel arrives damaged, late, or with uncertain temperature control, document the condition and contact the dispensing pharmacy. Keep the packaging while the issue is reviewed. Ask who is responsible for replacement decisions and whether there is a specific time window for reporting damage.
Normal appearance does not independently prove that storage requirements were met. Equally, the absence of an ice pack alone does not tell this site the requirements for a particular preparation. The pharmacist needs to assess the actual formulation, packaging, and delivery circumstances.
Keep a simple record for follow-up
Save the label, lot information, date received, and the instructions you were given. If the plan changes, obtain updated directions and clarify which instructions now apply. Keep medication questions separate from assumptions based on a subscription renewal email.
If you experience a suspected reaction, seek the appropriate care and share the identifying details with the clinical team. Read our side-effects guide and compounding guide before starting so you know which questions to resolve while the situation is calm.
Clarify the concentration and preparation.
Use the dosing-label guide to distinguish milligrams, milliliters, and device markings. Reconstitution questions explain why a research vial and a prescribed medicine are different. Timing, missed-use instructions, and course duration belong in the prescriber’s follow-up plan.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- NABP: state boards of pharmacy Directory for checking pharmacy credentials.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.